Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizoribine vs Cyclophosphamide in Refractory Nephrotic Syndrome
NCT02257697Phase 3Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Nov 2014
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mizoribine in nephrotic syndrome, sponsored by Asahi Kasei Corporation. Started Nov 2014; status: completed.
02
Drugs
mizoribine
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT02257697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257697.